PharmaCyte Biotech Inc (PMCB)

[oldmusky]

The share price has everything to do with two things. Time and outstanding shares.

The share total is so high that you have to own millions of shares to have any skin in the game.

They are going to need a lot of time to complete "a lengthy list" of tests required by the FDA. This is in no way a quick fix.

In order to pay bills and salaries they are going to need to create more shares to sell. This further dilution makes existing shareholders positions worth less.

Now with these new existing shares the company will have to sell them in bulk at a discount.

What is that discount price going to be when we are trading at 1/2 a penny? Probably between a tenth and 2 tenths of a penny maybe lower.

Then, those that bought those discounted shares will start selling massively at low prices holding the stock down. We have already seen this.

Now tragically diluted, with toxic finances selling shares every day, pmcb will move forward?

Eventually no-one will buy these shares, not even the discounted ones.

I just do not see this group of execs pulling this out of the fire.


WHO is making money here and Who has been making money all along, besides flippers?

WHO benefits from a long to do list from the FDA?

The answer to both questions is the same.